Overview

Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive Disorder

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
Clinical practice indicates that Quetiapine has sedating properties, and its sedative effects may play an important role in restoring quality of sleep in patients with various psychiatric conditions who frequently experience sleep disturbances as part of their illness. It is well known that depressive disorders are very frequently associated with significant sleep disturbance. Sleep disruption is a feature of Bipolar Disorder during both Depressed and Manic/Hypomanic episodes. Considering that Seroquel has good antidepressant properties (Calabrese, 2004), the investigators suggest that Seroquel's effect on sleep architecture contributes to its antidepressant properties.
Details
Lead Sponsor:
Queen's University
Collaborator:
AstraZeneca
Treatments:
Quetiapine Fumarate